Murray Urowitz

Murray Urowitz

UNVERIFIED PROFILE

Are you Murray Urowitz?   Register this Author

Register author
Murray Urowitz

Murray Urowitz

Publications by authors named "Murray Urowitz"

Are you Murray Urowitz?   Register this Author

100Publications

3562Reads

11Profile Views

Dr. Tselios, , reply.

J Rheumatol 2019 Jul 1. Epub 2019 Jul 1.

Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, University Health Network; Cardiology Department, Women's College Hospital, University of Toronto. Address correspondence to Dr. M.B. Urowitz, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, 399 Bathurst St., 1E-410B, Toronto, Ontario M5T 2S8, Canada. E-mail:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.190255DOI Listing
July 2019

Clinical Remission and Low Disease Activity Outcomes Over 10 Years in Systemic Lupus Erythematosus.

Arthritis Care Res (Hoboken) 2019 Jun 10;71(6):822-828. Epub 2019 May 10.

University Health Network, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.23720DOI Listing
June 2019

How can we define low disease activity in systemic lupus erythematosus?

Semin Arthritis Rheum 2019 Jun 16;48(6):1035-1040. Epub 2018 Oct 16.

University of Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, University Health Network, 399 Bathurst St. 1E-410B, Toronto, Ontario M5T 2S8, Canada. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00490172183048
Publisher Site
http://dx.doi.org/10.1016/j.semarthrit.2018.10.013DOI Listing
June 2019

All-cause, cause-specific and age-specific standardised mortality ratios of patients with systemic lupus erythematosus in Ontario, Canada over 43 years (1971-2013).

Ann Rheum Dis 2019 Jun 16;78(6):802-806. Epub 2019 Apr 16.

Center for Prognosis Studies in the Rheumatic Diseases, Toronto Lupus Clinic, University Health Network, University of Toronto, Toronto, Ontario, Canada

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2018-214802DOI Listing
June 2019

Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.

J Rheumatol 2019 May 15;46(5):492-500. Epub 2019 Jan 15.

From the Rheumatology/Division of Neuro and Inflammation Sciences, Department of Clinical and Experimental Medicine, Linköping University, Linköping; Department of Medicine, Unit of Rheumatology, Karolinska Institutet and Karolinska University Hospital, Stockholm; Department of Clinical Sciences Lund, Section of Rheumatology, Lund University, Lund; Unit for Clinical Therapy Research (ClinTRID), Karolinska University, Stockholm, Sweden; Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, Ontario; Division of Rheumatology, Centre Hospitalier Universitaire (CHU) de Québec - Université Laval, Quebec City, Quebec; Division of Rheumatology, Cumming School of Medicine - University of Calgary, Calgary, Alberta; Division of Rheumatology, Department of Medicine, McGill University Health Centre, Montreal, Quebec; Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia; Department of Medicine and Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada; Instituto Nacional de Ciencias Médicas y Nutrición, Mexico City, Mexico; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea; Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham; Centre for Rheumatology Research, University College, London; Lupus Research Unit, The Rayne Institute, St. Thomas' Hospital, King's College London School of Medicine, London; Lanarkshire Centre for Rheumatology, Hairmyres Hospital, East Kilbride, Scotland; Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health, The University of Manchester and UK National Institute for Health Research (NIHR) Manchester Biomedical Research Centre, Manchester University Foundation Trust, Manchester, UK; Cedars-Sinai/David Geffen School of Medicine at University of California at Los Angeles, Los Angeles, California; Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma; Department of Medicine, State University of New York (SUNY) Downstate Medical Center, Brooklyn, New York; Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama; Department of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Feinstein Institute for Medical Research, Manhasset, New York; Division of Rheumatology and Immunology, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina; Autoimmunity Institute, Allegheny Health Network, Pittsburgh, Pennsylvania; Northwestern University and Feinberg School of Medicine, Chicago, Illinois; Division of Rheumatology, Emory University School of Medicine, Atlanta, Georgia; University of California San Diego School of Medicine, La Jolla, California; Division of Rheumatology, Medical University of South Carolina, Charleston, South Carolina; Division of Rheumatology, Columbia University Medical Center, New York, New York, USA; Department of Rheumatology, Center for Rheumatology Research Fossvogur Landspitali University Hospital, Reyjkavik, Iceland; Autoimmune Disease Unit, Department of Internal Medicine, Hospital Universitario Cruces, BioCruces Health Research Institute, University of the Basque Country, Barakaldo; Josep Font Autoimmune Diseases Laboratory, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Spain; Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey; Copenhagen Lupus and Vasculitis Clinic, Centre for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Rheumatology, Kantousspital, Schaffhausen, Switzerland.

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.180713
Publisher Site
http://dx.doi.org/10.3899/jrheum.180713DOI Listing
May 2019

Antimalarial-induced Cardiomyopathy in Systemic Lupus Erythematosus: As Rare as Considered?

J Rheumatol 2019 Apr 15;46(4):391-396. Epub 2018 Oct 15.

From the University of Toronto Lupus Clinic, Toronto Western Hospital, Centre for Prognosis Studies in the Rheumatic Diseases, University Health Network; University of Toronto, Krembil Research Institute; Department of Cardiology, University of Toronto, Women's College Hospital; Mecklinger Family and Posluns Family Cardiac Catheterization Research Laboratory, Department of Medicine, Division of Cardiology, Mount Sinai Hospital, University of Toronto; Department of Laboratory Medicine and Pathobiology, University Health Network, Toronto General Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.180124DOI Listing
April 2019

Construction of a frailty index as a novel health measure in systemic lupus erythematosus.

J Rheumatol 2019 Apr 15. Epub 2019 Apr 15.

Department of Medicine, Division of Rheumatology, Dalhousie University, Halifax, Nova Scotia, Canada; Department of Community Health & Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada; Division of Geriatric Medicine, Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea;Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK; Instituto Nacional de Ciencias Medicas y Nutrición, Mexico City, Mexico; Cedars-Sinai/David Geffen School of Medicine at UCLA, Los Angeles, CA, USA; Divisions of Rheumatology and Clinical Epidemiology, Department of Medicine, McGill University, Montreal, Quebec, Canada; Division of Rheumatology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA; Department of Medicine, SUNY Downstate Medical Center, Brooklyn, NY, USA; Division of Rheumatology, CHU de Québec et Université Laval, Quebec City, Canada; Center for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, ON, Canada; Arthritis Research UK Epidemiology Unit, Faculty of Biology Medicine and Health, Manchester Academic Health Sciences Center, The University of Manchester, and NIHR Manchester Musculoskeletal Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Center Manchester, UK; Center for Rheumatology, Department of Medicine, University College London, UK; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Lupus Research Unit, The Rayne Institute, St Thomas' Hospital, King's College London School of Medicine, UK, London, UK; Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC, USA; Northwestern University and Feinberg School of Medicine, Chicago, IL, USA; Lupus Center of Excellence, Allegheny Health Network, Pittsburgh, PA, USA; Lanarkshire Center for Rheumatology, Hairmyres Hospital, East Kilbride, Scotland UK; Feinstein Institute for Medical Research, Manhasset, NY, USA; Autoimmune Diseases Research Unit, Department of Internal Medicine, BioCruces Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Barakaldo, Spain; Emory University School of Medicine, Division of Rheumatology, Atlanta, Georgia, USA Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey; Unit for clinical therapy research (ClinTRID), Karolinska Institute, Stockholm, Sweden; Department of Clinical Sciences Lund, Rheumatology, Lund University, Lund, Sweden. Josep Font Autoimmune Diseases Laboratory, IDIBAPS, Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Spain; Medical University of South Carolina, Charleston, South Carolina, USA; UCSD School of Medicine, La Jolla, CA, USA; Copenhagen Lupus and Vasculitis Clinic, 4242, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; University of Manitoba, Winnipeg, Manitoba, Canada; Hospital for Joint Diseases, NYU, Seligman Center for Advanced Therapeutics, New York NY; Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Center and Dalhousie University, Halifax, Nova Scotia, Canada. Funding for this work was provided by the Nova Scotia Health Authority Research Fund. Dr. Sang-Cheol Bae's work was supported in part by NRF-2017M3A9B4050335, Republic of Korea. Dr. Caroline Gordon's work was supported by Lupus UK and the NIHR /Wellcome Trust Clinical Research Facility. The Montreal General Hospital Lupus Clinic is partially supported by the Singer Family Fund for Lupus Research. Dr. Clarke holds The Arthritis Society Chair in Rheumatic Diseases at the University of Calgary. Dr. Paul R. Fortin presently holds a tier 1 Canada Research Chair on Systemic Autoimmune Rheumatic Diseases at Université Laval, and part of this work was done while he was still holding a Distinguished Senior Investigator of The Arthritis Society. Dr. Bruce is a National Institute for Health Research (NIHR) Senior Investigator and is supported by Arthritis Research UK, the NIHR Manchester Biomedical Centre and the NIHR/Wellcome Trust Manchester Clinical Research Facility. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health. Dr Isenberg and Dr Rahman are supported by and supported by the National Institute for Health, Research University College London Hospitals Biomedical Research Center. The Hopkins Lupus Cohort is supported by the NIH (grant AR43727 and 69572). Dr. Mary Anne Dooley's work was supported by the NIH (grant RR00046). Dr. Ramsey-Goldman's work was supported by the NIH (grants 5UL1TR001422-02, formerly 8UL1TR000150 and UL-1RR-025741, K24-AR-02318, and P60AR064464 formerly P60-AR- 48098). Dr. Ruiz-Irastorza is supported by the Department of Education, Universities and Research of the Basque Government. Dr. Soren Jacobsen is supported by the Danish Rheumatism Association (A3865) and the Novo Nordisk Foundation (A05990). Dr. John G. Hanly is supported by the Canadian Institutes of Health Research (grant MOP-88526). Address Correspondence to: Dr. John G Hanly, Division of Rheumatology, Nova Scotia Rehabilitation Centre (2nd Floor), 1341 Summer Street, Halifax, Nova Scotia, Canada, B3H 4K4.Email:

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.181338
Publisher Site
http://dx.doi.org/10.3899/jrheum.181338DOI Listing
April 2019

Atherosclerotic Vascular Events in Systemic Lupus Erythematosus: An Evolving Story.

J Rheumatol 2019 Feb 1. Epub 2019 Feb 1.

From the University of Toronto Lupus Clinic, Centre for Prognosis Studies in The Rheumatic Disease, Toronto Western Hospital, Toronto, Ontario, Canada. M.B. Urowitz, MD, FRCPC, Professor of Medicine, University of Toronto, and Senior Scientist, Krembil Research Institute, and Director, Centre for Prognosis Studies in The Rheumatic Disease and University of Toronto Lupus Clinic, Toronto Western Hospital; J. Su, MB, BSc, Biostatistician, Centre for Prognosis Studies in The Rheumatic Diseases, University of Toronto Lupus Clinic; D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto, Senior Scientist, Krembil Research Institute, Deputy Director, Centre for Prognosis Studies in The Rheumatic Disease and University of Toronto Lupus Clinic, Toronto Western Hospital. Address correspondence to Dr. M.B. Urowitz, Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western Hospital, 399 Bathurst St. 1E-410B, Toronto, Ontario M5T 2S8, Canada. E-mail: Accepted for publication January 14, 2019.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.180986DOI Listing
February 2019

Abnormal Cardiac Biomarkers in Patients with Systemic Lupus Erythematosus and No Prior Heart Disease: A Consequence of Antimalarials?

J Rheumatol 2019 Jan 1;46(1):64-69. Epub 2018 Aug 1.

From the Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, University Health Network; Cardiology Department, Women's College Hospital, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.171436DOI Listing
January 2019

Correction to: Psoriasis in systemic lupus erythematosus: a single-center experience.

Clin Rheumatol 2019 01;38(1):269

Centre for Prognosis Studies in the Rheumatic Diseases Toronto Western Hospital, University of Toronto Lupus Clinic, University Health Network, 399 Bathurst St. 1E-410B, Toronto, ON, M5T 2S8, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10067-018-4363-0DOI Listing
January 2019

Practice Variations in the Diagnosis, Monitoring, and Treatment of Systemic Lupus Erythematosus in Canada.

J Rheumatol 2018 Oct 1;45(10):1440-1447. Epub 2018 Aug 1.

From the Division of Rheumatology, University of Alberta, Edmonton, Alberta; Division of Rheumatology, McGill University, Montreal, Quebec; Alberta Research Centre for Health Evidence, Department of Pediatrics, University of Alberta, Edmonton, Alberta; Division of Rheumatology, CHU de Québec, Université Laval, Quebec City, Quebec; Division of Rheumatology, University of Toronto, Toronto, Ontario; Division of Rheumatology, University of Manitoba, Winnipeg, Manitoba, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.171307DOI Listing
October 2018

Canadian Rheumatology Association Recommendations for the Assessment and Monitoring of Systemic Lupus Erythematosus.

J Rheumatol 2018 Oct 1;45(10):1426-1439. Epub 2018 Sep 1.

From the Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, British Columbia; Division of Rheumatology, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta; Canadian Arthritis Patient Alliance; Division of Rheumatology, Department of Medicine, McGill University; Division of Rheumatology, Department of Medicine, Université de Montréal, Montreal; Division of Rheumatology, Department of Medicine, Université Laval, Quebec City, Quebec; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto; Division of Rheumatology, Department of Medicine, McMaster University, Hamilton, Ontario; Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia; Division of Rheumatology, Hospital for Sick Children, Department of Pediatrics, University of Toronto, Toronto, Ontario; Division of Rheumatology, Department of Medicine, University of Manitoba, Winnipeg, Manitoba; General Internal Medicine, McGill University Health Centre, McGill University, Montreal, Quebec; Cochrane Musculoskeletal Group, University of Ottawa, Ottawa; Division of Rheumatology, Department of Medicine, Western University, London, Ontario; Canadian Agency for Drugs and Technologies in Health, Ottawa; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton; Centre for Practice-changing Research, Ottawa Hospital Research Institute, Ottawa, Ontario.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.171459DOI Listing
October 2018

Cardiovascular and Pulmonary Manifestations of Systemic Lupus Erythematosus.

Curr Rheumatol Rev 2017 ;13(3):206-218

Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Lupus Clinic, University Health Network, Toronto, Ontario. Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1573397113666170704102444DOI Listing
August 2018

A novel lupus activity index accounting for glucocorticoids: SLEDAI-2K glucocorticoid index.

Rheumatology (Oxford) 2018 08;57(8):1370-1376

Toronto Western Hospital, Centre for Prognosis Studies in the Rheumatic Diseases, University of Toronto Lupus Clinic, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/key103DOI Listing
August 2018

Monophasic Disease Course in Systemic Lupus Erythematosus.

J Rheumatol 2018 Aug 1;45(8):1131-1135. Epub 2018 Jun 1.

From the Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.171319DOI Listing
August 2018

Smoking Is the Most Significant Modifiable Lung Cancer Risk Factor in Systemic Lupus Erythematosus.

J Rheumatol 2018 Mar 15;45(3):393-396. Epub 2018 Jan 15.

From The Research Institute of the McGill University Health Centre, Montreal; Université de Laval, Service de rheumatologie, Quebec City, Quebec; Toronto Western Hospital, Toronto, Ontario; Dalhousie University and Capital Health, Halifax, Nova Scotia; University of Manitoba, Winnipeg, Manitoba; Division of Rheumatology, University of Calgary, Cumming School of Medicine, Calgary, Alberta, Canada; Northwestern University Feinberg School of Medicine, Chicago, Illinois; Johns Hopkins University School of Medicine, Baltimore, Maryland; University of California at San Francisco, Department of Medicine, San Francisco, California; State University of New York-Downstate Medical Center, Brooklyn; The Feinstein Institute for Medical Research, Manhasset, New York; Therapeutic Radiology, Yale University, New Haven, Connecticut, USA; University of Birmingham, College of Medical and Dental Sciences, Birmingham; University College London, Faculty of Medicine, Department of Rheumatology, London, UK; Lund University Hospital, Lund, Sweden; The Hospital for Rheumatic Diseases, Hanyang University, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.170652DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834350PMC
March 2018

More Consistent Antimalarial Intake in First 5 Years of Disease Is Associated with Better Prognosis in Patients with Systemic Lupus Erythematosus.

J Rheumatol 2018 Jan 15;45(1):90-94. Epub 2017 Nov 15.

From the University of Toronto Lupus Clinic, Toronto Western Hospital, Centre for Prognosis Studies in the Rheumatic Diseases; University of Toronto, Toronto Western Research Institute, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.170645DOI Listing
January 2018

Reply.

Arthritis Care Res (Hoboken) 2017 12;69(12):1934

University of Toronto Lupus Clinic and Toronto Western Hospital, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.23309DOI Listing
December 2017

Evolution of Risk Factors for Atherosclerotic Cardiovascular Events in Systemic Lupus Erythematosus: A Longterm Prospective Study.

J Rheumatol 2017 Dec 1;44(12):1841-1849. Epub 2017 Nov 1.

From the Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.161121DOI Listing
December 2017

Comparison of systemic lupus erythematosus (SLE) patients managed early after diagnosis in specialty versus community care clinics.

Clin Rheumatol 2017 Aug 6;36(8):1773-1778. Epub 2017 Jun 6.

University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, 399 Bathurst Street, 1E-410B, Toronto, ON, M5T 2S8, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10067-017-3713-7DOI Listing
August 2017

Hospitalizations in Patients with Systemic Lupus Erythematosus in an Academic Health Science Center.

J Rheumatol 2017 08 15;44(8):1173-1178. Epub 2017 Jun 15.

From the University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.170072DOI Listing
August 2017

Defining Low Disease Activity in Systemic Lupus Erythematosus.

Arthritis Care Res (Hoboken) 2017 07;69(7):997-1003

University of Toronto, Krembil Research Institute, and Center for Prognostic Studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.23109DOI Listing
July 2017

The utility of lupus serology in predicting outcomes of renal transplantation in lupus patients: Systematic literature review and analysis of the Toronto lupus cohort.

Semin Arthritis Rheum 2017 06 21;46(6):791-797. Epub 2016 Sep 21.

Department of Medicine, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, EW, 1-412, 399 Bathurst St, Toronto, Ontario, Canada M5T 2S8; The Institute for Work and Health, Toronto, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semarthrit.2016.09.008DOI Listing
June 2017

Psoriasis in systemic lupus erythematosus: a single-center experience.

Clin Rheumatol 2017 Apr 6;36(4):879-884. Epub 2017 Feb 6.

Centre for Prognosis Studies in the Rheumatic Diseases Toronto Western Hospital, University of Toronto Lupus Clinic, University Health Network, 399 Bathurst St. 1E-410B, Toronto, ON, M5T 2S8, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10067-017-3566-0DOI Listing
April 2017

Disease Outcomes in Glucocorticosteroid-Naive Patients With Systemic Lupus Erythematosus.

Arthritis Care Res (Hoboken) 2017 Feb;69(2):252-256

University of Toronto and Toronto Western Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.22938DOI Listing
February 2017

Prevalence and associated factors of resting electrocardiogram abnormalities among systemic lupus erythematosus patients without cardiovascular disease.

Arthritis Res Ther 2017 Feb 10;19(1):31. Epub 2017 Feb 10.

Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, University of Toronto, EW, 1-412, 399 Bathurst Street, Toronto, Ontario, M5T 2S8, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13075-017-1240-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5301322PMC
February 2017

Systemic lupus erythematosus and pulmonary arterial hypertension: links, risks, and management strategies.

Open Access Rheumatol 2017 20;9:1-9. Epub 2016 Dec 20.

University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, University Health Network, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OARRR.S123549DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5191623PMC
December 2016

Does Renin-Angiotensin System Blockade Protect Lupus Nephritis Patients From Atherosclerotic Cardiovascular Events? A Case-Control Study.

Arthritis Care Res (Hoboken) 2016 10 19;68(10):1497-504. Epub 2016 Aug 19.

Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.22857DOI Listing
October 2016

Dr. Tselios, et al reply.

J Rheumatol 2016 09;43(9):1767

Centre for Prognosis Studies in the Rheumatic Diseases, University of Toronto Lupus Clinic, University Health Network, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.160749DOI Listing
September 2016

Hydroxychloroquine-Induced Cardiomyopathy in Systemic Lupus Erythematosus.

J Clin Rheumatol 2016 Aug;22(5):287-8

University of Toronto Lupus Clinic Centre for Prognosis Studies in the Rheumatic Diseases Toronto Western Hospital Toronto, Ontario, Canada Department of Medicine University of Toronto and Department of Medicine Women's College Hospital Toronto, Ontario, Canada Mecklinger Family and Posluns Family Cardiac Catheterization Research Laboratory Department of Medicine Division of Cardiology Mount Sinai Hospital University of Toronto Toronto, Ontario, Canada Fred A. Litwin Family Centre in Genetic Medicine Department of Medicine Mount Sinai Hospital University of Toronto Toronto, Ontario, Canada University Health Network Pathology Department Toronto General Research Institute Toronto, Ontario, Canada University of Toronto Lupus Clinic Centre for Prognosis Studies in the Rheumatic Diseases Toronto Western Hospital Toronto, Ontario, Canada

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RHU.0000000000000400DOI Listing
August 2016

Systemic lupus erythematosus.

Nat Rev Dis Primers 2016 06 16;2:16039. Epub 2016 Jun 16.

The London Lupus Centre, London Bridge Hospital, London, UK.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/nrdp201639
Publisher Site
http://dx.doi.org/10.1038/nrdp.2016.39DOI Listing
June 2016

Modified Framingham Risk Factor Score for Systemic Lupus Erythematosus.

J Rheumatol 2016 05 15;43(5):875-9. Epub 2016 Feb 15.

From the University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada.M.B. Urowitz, MD, FRCPC, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital; D. Ibañez, MSc, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital; J. Su, MB, BSc University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital; D.D. Gladman, MD, FRCPC, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.150983DOI Listing
May 2016

Dyslipidemia in systemic lupus erythematosus: just another comorbidity?

Semin Arthritis Rheum 2016 Apr 29;45(5):604-10. Epub 2015 Oct 29.

Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semarthrit.2015.10.010DOI Listing
April 2016

Mycophenolate Mofetil in Nonrenal Manifestations of Systemic Lupus Erythematosus: An Observational Cohort Study.

J Rheumatol 2016 Mar 15;43(3):552-8. Epub 2016 Jan 15.

From the Centre for Prognosis Studies in Rheumatic Diseases, University of Toronto Lupus Clinic, University Health Network, Toronto, Ontario, Canada.K. Tselios, MD, PhD, Centre for Prognosis Studies in Rheumatic Diseases, University of Toronto Lupus Clinic, University Health Network; D.D. Gladman, MD, FCRPC, Centre for Prognosis Studies in Rheumatic Diseases, University of Toronto Lupus Clinic, University Health Network; J. Su, MB, BSc, Centre for Prognosis Studies in Rheumatic Diseases, University of Toronto Lupus Clinic, University Health Network; M.B. Urowitz, MD, FRCPC, Centre for Prognosis Studies in Rheumatic Diseases, University of Toronto Lupus Clinic, University Health Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.150779DOI Listing
March 2016

Optimal Monitoring For Coronary Heart Disease Risk in Patients with Systemic Lupus Erythematosus: A Systematic Review.

J Rheumatol 2016 Jan 15;43(1):54-65. Epub 2015 Nov 15.

From the University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, University Health Network, Toronto Western Hospital, Toronto, Ontario, Canada.K. Tselios, MD, PhD, Clinical Research Fellow, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, University Health Network, Toronto Western Hospital; B.J. Sheane, MD, MB, BSc, BAO, Clinical Research Fellow, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, University Health Network, Toronto Western Hospital; D.D. Gladman, MD, FRCPC, Professor of Medicine, Senior Scientist, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, University Health Network, Toronto Western Hospital; M.B. Urowitz, MD, FRCPC, Professor of Medicine, Senior Scientist, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, University Health Network, Toronto Western Hospital.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.150460DOI Listing
January 2016

Lack of Interferon and Proinflammatory Cyto/chemokines in Serologically Active Clinically Quiescent Systemic Lupus Erythematosus.

J Rheumatol 2015 Dec 15;42(12):2318-26. Epub 2015 Nov 15.

From the University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, University Health Network; Division of Rheumatology, Department of Medicine, and Department of Immunology, University of Toronto; Arthritis Centre of Excellence, Division of Health Care and Outcomes Research, Toronto Western Hospital Research Institute, University Health Network; Arthritis Centre of Excellence, Division of Genetics and Development, Toronto Western Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.A.J. Steiman, MD, MSc, FRCP, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, University Health Network, and Division of Rheumatology, Department of Medicine, University of Toronto; D.D. Gladman, MD, FRCP, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, University Health Network, and Division of Rheumatology, Department of Medicine, University of Toronto, and Arthritis Centre of Excellence, Division of Health Care and Outcomes Research, Toronto Western Hospital Research Institute, University Health Network; D. Ibañez, MSc, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, University Health Network; B. Noamani, MSc, Arthritis Centre of Excellence, Division of Genetics and Development, Toronto Western Hospital Research Institute, University Health Network; C. Landolt-Marticorena, MD, PhD, FRCP, Division of Rheumatology, Department of Medicine, University of Toronto; M.B. Urowitz, MD, FRCP, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, University Health Network, and Division of Rheumatology, Department of Medicine, University of Toronto, and Arthritis Centre of Excellence, Division of Health Care and Outcomes Research, Toronto Wes

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.150040DOI Listing
December 2015

Utility of untimed single urine protein/creatinine ratio as a substitute for 24-h proteinuria for assessment of proteinuria in systemic lupus erythematosus.

Arthritis Res Ther 2015 Oct 24;17:296. Epub 2015 Oct 24.

University of Toronto Lupus Clinic, Toronto Western Hospital, Centre for Prognosis Studies on the Rheumatic Diseases, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13075-015-0808-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619322PMC
October 2015

SLEDAI-2K Does Not Conceal Worsening in a Particular System When There Is Overall Improvement.

J Rheumatol 2015 Aug 15;42(8):1401-5. Epub 2015 Jun 15.

From the University of Toronto, University of Toronto Lupus Clinic, Toronto Western Hospital, Centre for Prognosis Studies in the Rheumatic Diseases, and Toronto Western Research Institute, Toronto, Ontario, Canada.Z. Touma, MD, FACP, FACR, PhD, Assistant Professor of Medicine, University of Toronto Lupus Clinic, Toronto Western Hospital, Centre for Prognosis Studies in the Rheumatic Diseases; D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto, and Senior Scientist, Toronto Western Research Institute, and Co-director, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, University of Toronto; J. Su, MB, BSc; D. Ibañez, MSc, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital; M.B. Urowitz, MD, FRCPC, Professor of Medicine, University of Toronto, and Senior Scientist, Toronto Western Research Institute, and Director, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.141088DOI Listing
August 2015

Safety and efficacy of hCDR1 (Edratide) in patients with active systemic lupus erythematosus: results of phase II study.

Lupus Sci Med 2015 11;2(1):e000104. Epub 2015 Aug 11.

UCLA & Cedars-Sinai Medical Center , Los Angeles, California , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/lupus-2015-000104DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4538379PMC
August 2015

Anti-dsDNA and Antichromatin Antibody Isotypes in Serologically Active Clinically Quiescent Systemic Lupus Erythematosus.

J Rheumatol 2015 May 1;42(5):810-6. Epub 2015 Mar 1.

From the University of Toronto; Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western Hospital; Toronto Western Hospital; Arthritis Centre of Excellence, Division of Genetics and Development, Toronto Western Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.A.J. Steiman, MD, FRCPC, Rheumatology Fellow, University of Toronto, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital; M.B. Urowitz, MD, FRCPC, Professor of Medicine, University of Toronto, and Director, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital; D. Ibañez, MSc, Biostatistician, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital; T.T. Li, MSc, Medical Student, Arthritis Centre of Excellence, Division of Genetics and Development, Western Hospital Research Institute, University Health Network; D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto, and Deputy Director, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital; J. Wither, MD, PhD, FRCPC, Professor of Medicine, University of Toronto, Arthritis Centre of Excellence, Division of Genetics and Development, Toronto Western Hospital Research Institute, University Health Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.140796DOI Listing
May 2015

Interferon-α induces altered transitional B cell signaling and function in Systemic Lupus Erythematosus.

J Autoimmun 2015 Apr 9;58:100-10. Epub 2015 Feb 9.

Arthritis Centre of Excellence, Toronto Western Hospital Research Institute, University of Toronto Faculty of Medicine, Toronto, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaut.2015.01.009DOI Listing
April 2015

Costs associated with severe and nonsevere systemic lupus erythematosus in Canada.

Arthritis Care Res (Hoboken) 2015 Mar;67(3):431-6

McGill University Health Centre, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.22452DOI Listing
March 2015

Anti-nucleosome antibodies outperform traditional biomarkers as longitudinal indicators of disease activity in systemic lupus erythematosus.

Rheumatology (Oxford) 2015 Mar 5;54(3):449-57. Epub 2014 Sep 5.

Arthritis Centre of Excellence, Division of Genetics and Development, Toronto Western Hospital Research Institute, University Health Network (UHN), Ontario Institute for Cancer Research, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, University Health Network, Division of Biostatistics, Dalla Lana School of Public Health, Department of Medicine, University of Toronto, Arthritis Centre of Excellence, Division of Health Care and Outcomes Research, Toronto Western Hospital Research Institute, University Health Network, Toronto, ON, Centre de recherche du CHU de Québec, CHU de Québec, Division of Rheumatology, Department of Medicine, CHU de Québec and Faculty of Medicine, Université Laval, Quebec City, QC, Department of Immunology, Department of Medical Biophysics and Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada. Arthritis Centre of Excellence, Division of Genetics and Development, Toronto Western Hospital Research Institute, University Health Network (UHN), Ontario Institute for Cancer Research, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, University Health Network, Division of Biostatistics, Dalla Lana School of Public Health, Department of Medicine, University of Toronto, Arthritis Centre of Excellence, Division of Health Care and Outcomes Research, Toronto Western Hospital Research Institute, University Health Network, Toronto, ON, Centre de recherche du CHU de Québec, CHU de Québec, Division of Rheumatology, Department of Medicine, CHU de Québec and Faculty of Medicine, Université Laval, Quebec City, QC, Department of Immunology, Department of Medical Biophysics and Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada. Arthritis Centre of Excellence, Division of Genetics and Development, Toronto Western Hospital Research Institute, University

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/keu326DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334682PMC
March 2015

Isolated hematuria and sterile pyuria may indicate systemic lupus erythematosus activity.

J Rheumatol 2015 Mar 15;42(3):437-40. Epub 2015 Jan 15.

From the University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada.Jonathan Y.C. Ding was the recipient of the Canadian Rheumatology Association Roche Summer Studentship.J.Y.C. Ding, BSc, Medical Student, University of Toronto; D. Ibañez, MSc, Biostatistician, Centre for Prognosis Studies in the Rheumatic Diseases; D.D. Gladman, MD, FRCPC, Professor of Medicine, Senior Scientist, University of Toronto; M.B. Urowitz, MD, FRCPC, Professor of Medicine, Senior Scientist, University of Toronto.

View Article

Download full-text PDF

Source
http://www.jrheum.org/cgi/doi/10.3899/jrheum.140415
Publisher Site
http://dx.doi.org/10.3899/jrheum.140415DOI Listing
March 2015

Switching treatment between mycophenolate mofetil and azathioprine in lupus patients: indications and outcomes.

Arthritis Care Res (Hoboken) 2014 Dec;66(12):1905-9

University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.22364DOI Listing
December 2014

Prolonged clinical remission in patients with systemic lupus erythematosus.

J Rheumatol 2014 Sep 1;41(9):1808-16. Epub 2014 Aug 1.

From the Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital; University of Toronto, Toronto, Ontario, Canada.A.J. Steiman, MD, FRCPC, Rheumatology Fellow; M.B. Urowitz, MD, FRCPC, Professor of Medicine, Director; D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto, and the Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital; D. Ibañez, MSc, Biostatistician, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital; A. Papneja, Medical Student, Toronto Western Hospital Research Institute, University Health Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.131137DOI Listing
September 2014

American College of Rheumatology criteria at inception, and accrual over 5 years in the SLICC inception cohort.

J Rheumatol 2014 May 1;41(5):875-80. Epub 2014 Apr 1.

From the Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, Ontario, Canada; Instituto Nacional de Ciencias Medicas y Nutricion, Mexico City, Mexico; Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK; Department of Rheumatology, Hospital for Rheumatic Diseases and Hanyang University Medical Center, Seoul, Korea; Divisions of Clinical Immunology/Allergy and Clinical Epidemiology, Montreal General Hospital and McGill University Health Centre, Montreal, Quebec, Canada; Centre Hospitalier Universitaire de Québec et Université Laval, Quebec City, Quebec, Canada; Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada; Centre for Rheumatology Research, University College, London, UK; Cedars-Sinai/David Geffen School of Medicine, University of California, Los Angeles, California, USA; Department of Medicine, State University of New York Downstate Medical Center, Brooklyn, New York, USA; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Institute of Inflammation and Repair, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK; Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA; Department of Rheumatology, University Hospital Lund, Lund, Sweden; Division of Rheumatology and Immunology, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA; Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama, Birmingham, Alabama, USA; Center for Rheumatology Research, Landspitali University Hospital, Reyjkavik, Iceland; Northwestern University and Feinber

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.130704DOI Listing
May 2014

Time to recovery from proteinuria in patients with lupus nephritis receiving standard treatment.

J Rheumatol 2014 Apr 15;41(4):688-97. Epub 2014 Jan 15.

From the University of Toronto Lupus Clinic, Toronto Western Hospital, Centre for Prognosis Studies in the Rheumatic Diseases, and the Toronto Western Research Institute, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.130005
Publisher Site
http://dx.doi.org/10.3899/jrheum.130005DOI Listing
April 2014

Do current arterial hypertension treatment guidelines apply to systemic lupus erythematosus patients? a critical appraisal.

Semin Arthritis Rheum 2014 Feb 15;43(4):521-5. Epub 2013 Aug 15.

Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, University Health Network, 399 Bathurst St, Toronto, Ontario, Canada M5T 2S8.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semarthrit.2013.07.007DOI Listing
February 2014

Assessment of coronary risk based on cumulative exposure to lipids in systemic lupus erythematosus.

J Rheumatol 2013 Dec 15;40(12):2006-14. Epub 2013 Oct 15.

From the University of Toronto Lupus Clinic and the Centre for Prognosis Studies in the Rheumatic Diseases, Toronto, Ontario, Canada; The University of Melbourne Departments of Medicine and Rheumatology, St. Vincent's Hospital, Melbourne, Victoria, Australia; Division of Cardiology, Women's College Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.121273DOI Listing
December 2013

The early protective effect of hydroxychloroquine on the risk of cumulative damage in patients with systemic lupus erythematosus.

J Rheumatol 2013 Jun 15;40(6):831-41. Epub 2013 Apr 15.

Division of Rheumatology, Department of Medicine, University of Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.120572DOI Listing
June 2013

Systemic lupus erythematosus: an update on current pharmacotherapy and future directions.

Expert Opin Biol Ther 2013 May 23;13(5):723-37. Epub 2013 Jan 23.

University of Toronto, Institute of Medical Science, Lupus Clinic, Toronto Western Hospital, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.2013.764411DOI Listing
May 2013

Recommendations for frequency of visits to monitor systemic lupus erythematosus in asymptomatic patients: data from an observational cohort study.

J Rheumatol 2013 May 1;40(5):630-3. Epub 2013 Mar 1.

University of Toronto Lupus Clinic and the Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.121094DOI Listing
May 2013

Skin nontuberculous mycobacterial infection in systemic lupus erythematosus: an unusual skin infection mimicking lupus vasculitis.

Semin Arthritis Rheum 2013 Apr 16;42(5):498-506. Epub 2013 Jan 16.

Hospital Library, The Hospital for Sick Children, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semarthrit.2012.08.002DOI Listing
April 2013

In memoriam - Hugh A. Smythe, 1927-2012.

J Rheumatol 2013 Apr;40(4):343-7

Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.121357DOI Listing
April 2013

Comparison of three anti-dsDNA assays: performance and correlation with systemic lupus erythematosus disease activity.

Clin Biochem 2013 Mar 12;46(4-5):317-20. Epub 2012 Dec 12.

Department of Clinical Biochemistry, University Health Network, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00099120120069
Publisher Site
http://dx.doi.org/10.1016/j.clinbiochem.2012.12.004DOI Listing
March 2013

Vaccination and auto-immune rheumatic diseases: lessons learnt from the 2009 H1N1 influenza virus vaccination campaign.

Curr Opin Rheumatol 2013 Mar;25(2):164-70

University of Toronto, Toronto Western Research Institute, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/BOR.0b013e32835d2b7bDOI Listing
March 2013

Systemic lupus erythematosus disease activity Index 2000 Responder Index 50: sensitivity to response at 6 and 12 months.

Rheumatology (Oxford) 2012 Oct 19;51(10):1814-9. Epub 2012 Jun 19.

Department of Medicine, Division of Rheumatology, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
https://academic.oup.com/rheumatology/article-lookup/doi/10.
Publisher Site
http://dx.doi.org/10.1093/rheumatology/kes146DOI Listing
October 2012

High-sensitivity C-reactive protein as a marker of cardiovascular risk in systemic lupus erythematosus.

Arthritis Rheum 2012 Sep;64(9):3052-3

Toronto Western Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.34541DOI Listing
September 2012

Validation of a large-scale clinical examination for international medical graduates.

Can Fam Physician 2012 Jul;58(7):e408-17

University of Toronto, Post Graduate Medical Education, 500 University St, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395548PMC
July 2012

Long-term outcome of early neuropsychiatric events due to active disease in systemic lupus erythematosus.

Arthritis Care Res (Hoboken) 2012 Jun 30;64(6):833-7. Epub 2012 Jan 30.

Centre for Prognosis Studies in Rheumatic Diseases and Toronto Western Hospital, 399 Bathurst Street, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.21624DOI Listing
June 2012

Evaluation of clinical outcomes and renal vascular pathology among patients with lupus.

Clin J Am Soc Nephrol 2012 May 22;7(5):757-64. Epub 2012 Mar 22.

Division of Rheumatology, Department of Medicine, University Health Network, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2215/CJN.02870311DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3338275PMC
May 2012

University of Toronto Lupus Clinic turns 40.

J Rheumatol 2012 May;39(5):1074-7

University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.111581DOI Listing
May 2012

Outcomes in patients with systemic lupus erythematosus with and without a prolonged serologically active clinically quiescent period.

Arthritis Care Res (Hoboken) 2012 Apr;64(4):511-8

University of Toronto Lupus Clinic and Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.21568DOI Listing
April 2012

Ability of non-fasting and fasting triglycerides to predict coronary artery disease in lupus patients.

Rheumatology (Oxford) 2012 Mar 24;51(3):528-34. Epub 2011 Nov 24.

Toronto Western Hospital, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/ker339DOI Listing
March 2012

Prevalence and risk factors for liver biochemical abnormalities in Canadian patients with systemic lupus erythematosus.

J Rheumatol 2012 Feb 15;39(2):254-61. Epub 2011 Dec 15.

Division of Health Care and Outcome Research, Toronto Western Research Institute, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.110310DOI Listing
February 2012